Literature DB >> 8623544

HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression.

S Kanangat1, J S Babu, D M Knipe, B T Rouse.   

Abstract

Pathological effects of herpes simplex virus (HSV) can result due to a combination of direct viropathic effects and immunological reactions to viral antigens. The immunological reactions are orchestrated by a variety of cytokines and chemokines released by the host cells. Therefore, the cytokine gene expression in response to HSV-1 infection in a permissive murine cell line was investigated. The data demonstrate that HSV-1 induced a selective activation of IL-6 gene expression at the mRNA and protein levels, in the permissive cell line. The cell line used was capable of expressing IL-1, IL-7, and IL-10 in addition to IL-6, upon lipopolysaccharide stimulation. UV or heat-inactivated viruses were unable to upregulate IL-6 expression. However, mutant HSV-1 strains lacking fully functional ICP0, ICP4, ICP8, or ICP27 genes, thereby rendering them replication incompetent or impaired in in vitro cell growth (ICP0), enhanced IL-6 expression selectively. Considering the role of IL-6 in inflammation, immune response, and its known association with increased levels of MyD116 and GADD 34 mRNAs (genes involved in the prevention of apoptotic death of cells), the present data may have relevance to HSV-1-mediated diseases as well as to the prevalence of HSV-1 in the host.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623544     DOI: 10.1006/viro.1996.0250

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

Review 1.  Molecular diagnosis of herpes simplex virus infections in the central nervous system.

Authors:  Y W Tang; P S Mitchell; M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 3.  Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?

Authors:  James R Smiley
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Repression of host RNA polymerase II transcription by herpes simplex virus type 1.

Authors:  C A Spencer; M E Dahmus; S A Rice
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  The inflammasome NLRP3 plays a protective role against a viral immunopathological lesion.

Authors:  Fernanda Gimenez; Siddheshvar Bhela; Pranay Dogra; Lorena Harvey; Siva Karthik Varanasi; Ujjaldeep Jaggi; Barry T Rouse
Journal:  J Leukoc Biol       Date:  2015-10-29       Impact factor: 4.962

6.  Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis.

Authors:  Sachin Mulik; Shalini Sharma; Amol Suryawanshi; Tamara Veiga-Parga; Pradeep B J Reddy; Naveen K Rajasagi; Barry T Rouse
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

7.  Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.

Authors:  M Zheng; S Deshpande; S Lee; N Ferrara; B T Rouse
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 8.  Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization.

Authors:  Fernanda Giménez; Amol Suryawanshi; Barry T Rouse
Journal:  Prog Retin Eye Res       Date:  2012-08-07       Impact factor: 21.198

9.  Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes.

Authors:  S R Paludan
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells.

Authors:  Hui Li; Jing Zhang; Ashok Kumar; Mei Zheng; Sally S Atherton; Fu-Shin X Yu
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.